American Society for Apheresis
European Federation of Neurological Societies/European Academy of Neurology (EAN)
American Academy of Neurology
In 2008, the University of California San Diego (UCSD) introduced a plan aimed at reducing the overutilization of intravenous immunoglobulin (IVIg) by using plasma exchange instead of IVIg in suitable cases. The collaboration among neurology, apheresis and pharmacy was essential to driving change.
The collaborative approach helped drive efforts to manage IVIg utilization and minimize costs using plasma exchange as an alternative therapy. Given current healthcare trends and financial constraints, plasma exchange could provide institutions the opportunity to reduce costs and provide an equally efficacious alternative in stated patient populations.
Possible patient reactions
Reactions to transfused blood products can include1
Restricted to prescription use only
1AABB (ed.), et al., Circular of Information for the Use of Human Blood and Blood Components. 2006, tenth edition, Council of Europe Publishing, Seattle, WA.
2American Society for Apheresis. Guidelines for therapeutic apheresis clinical privileges. J Clin Apher. 2007;22(3):181-182.
Products available in select markets.